WASHINGTON (Reuters) - U.S. regulators approved a new AIDS treatment made by Merck & Co, the first in a new class of drugs aimed at preventing replication of the virus, Merck said on Friday.
WASHINGTON (Reuters) - U.S. regulators approved a new AIDS treatment made by Merck & Co, the first in a new class of drugs aimed at preventing replication of the virus, Merck said on Friday.